Court Rules FDA Must Restore Safeguards on Dangerous Abortion Pill That Hurts Women
Life News
Source: lifenews.com
Page 43 - Risk Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Risk Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Risk Evaluation Today - Breaking & Trending Today
FDA Approves Elranatamab for Multiple Myeloma
Elranatamab is an off-the-shelf, B-cell maturation antigen CD3-targeted bispecific antibody.
Source: medscape.com
Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...
Source: prnewswire.com
FDA Approves Hepzato Kit for Metastatic Uveal Melanoma
The Hepzato Kit is a direct-to-liver therapy for patients with uveal melanoma with hepatic metastases.
Source: curetoday.com
FDA Roundup: August 15, 2023
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced a...
Source: prnewswire.com